Browse studies

Find your next paid study

27,375 recruiting studies available now

Children's Health in the Heartland Study

The Heartland Study is a prospective, observational study that will enroll up to 2,600 pregnant participants across the Heartland States in the U.S.. The obje…

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Heartland Health Research AllianceNCT05492708

Observational

Effectiveness of 'Cepham Supplement' on Hot Flash Severity/Frequency and Menopausal Symptoms in Postmenopausal Women: A Randomized Double-Blind Placebo-Controlled Trial

The goal of this clinical trial is to learn if a daily nutritional supplement can reduce hot flashes and other menopausal symptoms in postmenopausal women. Th…

D008593

Estimated

~$10 – $750

Actual pay is set by the research site.

Jacksonville UniversityNCT06939868

Observational

Combined Circulatory and Dietary Interventions for Neuropathy (CDIN)

The purpose of this study is to evaluate the effectiveness of three different interventions in improving neuropathy symptoms in individuals aged 35-85 with mod…

Diabete Type 2Neuropathy, Painful

Estimated

~$10 – $750

Actual pay is set by the research site.

Loma Linda UniversityNCT07213843

Observational

PCOM2 - The Physician Communication Intervention, Version 2.0" for "Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake"

Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adol…

HPV InfectionPreventive Health Services

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT05336240

Phase 1

Pediatric And Young Adult Leukemia Adoptive Therapy (PLAT)-08: A Phase 1 Study Of SC-DARIC33 In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

A phase 1, open-label, non-randomized study enrolling pediatric and young adult patients with relapsed or refractory CD33+ leukemia with and without prior hist…

Acute Myeloid LeukemiaAcute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Seattle Children's HospitalNCT05105152

Phase 1

A Phase 1/2, Multicentre, Open-label Clinical Trial of DT-7012 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Participants With Selected Advanced Solid Tumors (DOMISOL, DOmain_therapeutics Monoclonal antIbody for SOLid Tumors)

This is a phase 1/2, dose-escalation, clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of DT-7012 (an anti-…

Advanced Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Domain Therapeutics Australia Pty LtdNCT06819735

A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding

This is a Phase 4 observational study designed to assess the impact of Palynziq ® (pegvaliase) treatment in pregnant women with PKU and on their offspring who …

Phenylketonuria, Maternal

Estimated

~$10 – $1,050

Actual pay is set by the research site.

BioMarin PharmaceuticalNCT05579548

Observational

Evaluating the Impact of Remote Therapeutic Monitoring on Knee Arthroplasty Recovery

The main goal of this study is to see if there is a connection between the social and economic resources available in a patient's neighborhood (measured by the…

Total Knee ArthroplastyKnee ReplacementKnee Replacement Arthroplasty+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of ChicagoNCT06968143

Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens

This study sets out to register imaging of small biopsy specimens obtained during bronchoscopy using full-field optical coherence tomography against standard h…

Lung CancerSarcoidosis

Estimated

~$10 – $750

Actual pay is set by the research site.

Johns Hopkins UniversityNCT05171478

Phase 2

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of WAL0921 in Patients With Glomerular Kidney Diseases and Proteinuria

This is an adaptive prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy, pharmacokinetics, and pharm…

Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Walden BiosciencesNCT06466135

Phase 2

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

This phase II trial studies how well canakinumab works for the treatment of low- or intermediate-risk myelodysplastic syndrome or chronic myelomonocytic leukem…

Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Chronic Myelomonocytic Leukemia+3 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT04239157

Phase 1

IMetelstat and Azacitidine With or Without Venetoclax GIveN in rElapsed Acute Myeloid Leukemia (IMAGINE Trial)

IMAGINE is a two-part trial to evaluate the safety and preliminary efficacy of imetelstat in combination with azacitidine with or without venetoclax in patient…

Relapsed Acute Myeloid Leukemia

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Douglas TremblayNCT07320235